Linden Advisors’s AMC Robotics AMCI Stock Holding History

Linden Advisors’s Portfolio AMCI Stock Details AMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300,000	Closed	-$3.17M	–	333
2023 Q3	$3.17M	Hold	300,000	–	–	0.03%	195
2023 Q2	$3.11M	Hold	300,000	–	–	0.03%	205
2023 Q1	$3.09M	Buy	+300,000	New	+$3.06M	0.03%	221

Other funds holding AMCI

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Linden Advisors's AMCI Position: Q4 2023 in Review

Linden Advisors sold out of AMC Robotics (AMCI) in Q4 2023, closing a stake of 300,000 shares — an estimated $3.17M sold.

Linden Advisors first reported a position in AMCI in Q1 2023 and held it in 3 quarters. The position peaked at $3.17M in Q3 2023. 22 funds tracked by Wall St. Rank hold AMCI as of Q4 2023.

Linden Advisors reported no remaining AMC Robotics position as of Q4 2023 after selling out during the quarter.
Linden Advisors sold 300,000 AMC Robotics shares in Q4 2023, an estimated $3.17M.
Linden Advisors first reported a position in AMC Robotics in Q1 2023 and held it in 3 quarters.
Linden Advisors's AMC Robotics position peaked at $3.17M in Q3 2023.
22 funds tracked by Wall St. Rank held AMC Robotics as of Q4 2023.

Based on Linden Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.